Blood Orange Kush (Cannabis flos Canopy Growth): lineage from Lemon Kush and limonene in the profile
Blood Orange Kush enters Polish pharmacies exclusively under the Spectrum Therapeutics brand. We gather what is known about the strain: lineage confirmed by the breeder, terpene profile from one source, and the state of evidence for limonene.
| Strain card | Blood Orange Kush |
|---|---|
| Producers | Canopy Growth (1 pharmacy position) |
| Medical brand | the same as the producer |
| Alternative names | none |
| Category according to sources | indica |
| Leading terpene | limonene |
| Other terpenes | linalool myrcene |
| Lineage | established Lemon Kush × Guava Kush |
| Source consistency | one source |
- Who supplies it. Exclusively Canopy Growth, so there is nothing to compare versions, and a supply break means the strain is unavailable, not another version of it.
- Profile. Limonene leads, followed by linalool, myrcene. We do not provide percentage shares because sources calculate them against different totals.
- Origin. Established lineage, parents are Lemon Kush and Guava Kush.
- What is missing. The profile describes one source, so there is nothing to compare it with.
Where does Blood Orange Kush come from and who provides its lineage?
Blood Orange Kush was created by crossing Lemon Kush with Guava Kush, and this lineage is provided by the official catalog of Canopy Growth, the owner of the Spectrum Therapeutics brand. In Polish pharmacies, the flower of this strain is issued under the commercial name with the Spectrum component, so the patient primarily sees the producer’s brand on the packaging, not the cultivar name.
The term “kush” in the name tempts one to look for family ties. This term is shared by ten strains in this cluster: half have established parents, and half do not have any at all (Hindu Kush, OG Kush, Pink Kush, Master Kush, and Afghan Kush). Blood Orange Kush belongs to the first group, but not because its name reveals anything, but because the breeder described the cross directly on their own page. The common word does not prove kinship in either direction: it neither confirms nor excludes it.
Neither Lemon Kush nor Guava Kush is available independently in Polish pharmacy circulation, so the lineage cannot be verified by comparing it with parents available by prescription. Only the breeder’s declaration remains, along with what it implies for the description. The strain is classified as indica, but this classification comes from one source and speaks more about how sellers organize their catalog than about a measured property of the plant.
Who introduces this strain to Polish pharmacies?
One producer. Blood Orange Kush enters Polish circulation exclusively as flower from the Spectrum Therapeutics brand, which is the medical line of the Canopy Growth group. There is no second pharmacy version of this strain, so there is nothing to compare between suppliers: the differences that patients usually ask about simply do not arise.
| Producer | What is on the packaging | How this version differs |
|---|---|---|
| Spectrum Therapeutics (Canopy Growth group) | commercial name with the Spectrum component, strain name as a suffix | the only version in circulation, no second supplier for comparison |
One row in such a table is not a flaw in the comparison. For strains supplied by several producers, batch documentation, packaging methods, and declared raw material processing are compared. Here, there is nothing to build such a comparison on, and it is more honest to write this than to fill in the columns with generalities about quality.
The exclusivity of the supplier has another effect that is rarely discussed. A break in the supply chain or a change in wholesale orders is enough for the strain to disappear from pharmacies for many weeks, while with several suppliers, the same cultivar could remain on the shelf. The current state and how many positions this producer currently has can be found in the list of currently available strains, and a broader description of the supplier itself is collected in a separate entry about the Spectrum Therapeutics brand.
What does the flower of this strain smell like?
Citrusy, with a distinct accent of bitter orange peel, against a backdrop of a milder floral and earthy note. At least that is how catalogs describe it, as aroma is not a quantity measured in the analysis certificate. The description of the smell remains a report from a person who felt it, not a repeatable result between batches of raw material.
The terpene profile for this strain is provided by one source, the Polish database budcare.pl, and lists limonene as the leading position, followed by linalool, and then myrcene. The first is responsible for the citrus impression, the second adds a floral-lavender tone, and the third is earthy and slightly spicy. The commercial name suggests exactly the same association as the aroma description, which can be misleading: names are arranged based on impression, not on analysis results.
You will not find a single percentage number for the aroma components here, and this is a decision, not an oversight. Public listings for the Polish market sum to 46, 73, or 83 percent at different times, which only means that each counts differently and does not state what its fraction refers to. The order of positions in the profile carries information; a percentage next to the name would be a facade of precision.
When does the strain start to take effect and how long does it last?
The course is determined by the method of intake, and the cultivar takes a back seat here. No one has announced pharmacokinetic measurements for Blood Orange Kush, and in fact, none have been announced for any strain in this listing, so the ranges given below describe the absorption of the flower and that is all that can be said about it.
The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, because pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After ingestion | |
|---|---|---|
| First sensations | after a few minutes | from half an hour to two |
| Onset | another ten to thirty minutes | slow, over several hours |
| Total duration | within two to four hours | after six, sometimes eight hours |
| Typical error | none | taking a dose after thirty minutes, which gives both doses at once |
For this strain, one practical caveat arises: the method of administration is determined by the attending physician, not the description in the seller’s catalog, and it is the physician who decides whether the above ranges are relevant for the patient at all.
What has really been shown in studies on the leading terpene?
Two studies on rodents, and nothing beyond that. Both available studies concern isolated limonene administered to animals via injection, not the inhalation of Blood Orange Kush flower by the patient. They describe the property of a single molecule under laboratory conditions, not the effect that can be expected from this strain.
| Study | Model and route of administration | What was shown |
|---|---|---|
| do Vale TG et al., 2002 Phytomedicine PMID:12587690 |
rodent (mouse, intraperitoneal administration) | Limonene administered intraperitoneally in mice showed muscle relaxant effects (rota-rod test) from a dose of 50 mg/kg and prolonged sleep time induced by pentobarbital at a dose of 200 mg/kg (about 2.6 times); in the elevated plus maze test, already at a dose of 5 mg/kg, it reduced the number of entries into the open arms, which the authors described as an anxiogenic effect, not anxiolytic. |
| Fakhri S et al., 2025 Behavioural Pharmacology PMID:40622197 |
rodent (rat and mouse) | Limonene reduced paw swelling induced by carrageenan in rats and pain responses in the formalin test in mice; the effect was linked to the l-arginine/nitric oxide/cGMP/KATP channel pathway and involvement of opioid and benzodiazepine receptors. |
No anxiolytic effect of limonene has been demonstrated in humans. It has also not been shown that isolated limonene has anxiolytic effects in animals; the only available data from the elevated plus maze test showed an opposite effect, reducing the number of entries into the open arms even at a low dose.
The rest of what circulates about the strain has a completely different status. The composition of the profile is described by one source, so there is nothing to compare it with or confirm, and descriptions of feelings after this strain come from patient reports and seller materials and are not data. A broader discussion of the terpene itself is collected in a separate entry about limonene.
What side effects have been reported after this strain?
None. Not because of the exceptional mildness of this flower, but because the pharmacotherapy safety registry assigns reports to the medicinal product along with its batch, and the name of the cultivar is not a unit in it. Therefore, no separate listing for Blood Orange Kush is maintained, and the rest of this section speaks about the raw material.
Reports of adverse effects are collected for the medicinal product with a batch number, not for the strain name, so the following pertains to hemp flower as a group of raw materials. The most commonly reported effects are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically because public listings for hemp flower in Poland do not separate them by individual products.
One caveat pertains directly to this strain. Since it is supplied by one producer, any potential report will go to the documentation of one product and will not be distributed across several pharmacy versions bearing the same strain name.
Can the vaporization temperature be adjusted for limonene?
Not in the way popular tables suggest. Vaporization does not start only at the boiling point, but gradually increases with temperature, and the value set on the device describes the heating element or air, not the flower itself. Targeting a single molecule is therefore based on a misunderstanding.
For this strain, the data turns out to be unusually good. All three positions in its profile fall within the top six terpenes, to which the PubChem database assigns a boiling point along with the pressure at which it was measured; out of the eleven terpenes present in this project, only that many have a record suitable for comparison with others. For comparison, humulene was measured at a pressure of 3 mm Hg, nearly in a vacuum, and for bisabolol and farnesene, the database does not provide a boiling point at all.
However, no recommendations arise from comparable numbers. How much terpene actually reaches the lungs and blood in humans has not been measured, and the method of administration is determined by the attending physician, as the raw material is dispensed by prescription. The mechanism of vaporization and the reasons why temperature tables contradict each other are detailed in a separate entry about the evaporation of terpenes from flower.
Which cultivars from Polish pharmacies are its siblings?
None. The pedigree chart of this listing does not indicate a single strain available in Polish pharmacies that shares a parent with Blood Orange Kush. Neither Lemon Kush nor Guava Kush is issued separately in our market, and their other offspring have not entered Polish circulation.
An empty sibling list with a known lineage can be a correct result, not a gap in the data. Kinship arises when two cultivars share an identified parent present in the same listing; broad families of style or landraces do not create such ties, as they are categories, not individual strains. Adding neighbors here by intuition would create false connections between parties.
However, eight strains from the same producer stand next to each other in the catalog, and it is easy to confuse this proximity with kinship. A common supplier describes the supply chain, not the genetics of the plant, just as a repeated word in the commercial name does. A patient looking for something with a similar character has nothing to grasp on the lineage side and is left with a comparison based on the terpene profile, which relies on one source, or simply a conversation with the attending physician. The only thing known for sure about the origin of this strain is what the breeder recorded, and on that note, the topic closes.
Frequently asked questions about Blood Orange Kush
Is Blood Orange Kush an indica strain?
Yes, it is described by one source and only on that basis. The classification as indica comes from the seller’s catalog, not from measurement, so it is more of a label organizing the list than a characteristic of the plant confirmed by research.
Under what name will I find this strain in the pharmacy?
Under the commercial name with the Spectrum component. In Polish circulation, the flower of this strain comes exclusively from Spectrum Therapeutics, the medical brand of the Canopy Growth group, and that brand is primarily visible on the packaging.
What terpenes are described in the profile of this strain?
Limonene as the leading position, followed by linalool and myrcene. The composition is provided without percentage shares because sources do not disclose what their numbers refer to, and their sums do not agree between databases.
Does limonene have anxiolytic effects?
This has not been demonstrated in humans. In the only available test on mice, isolated limonene reduced the number of entries into the open arms of the maze, which the authors described as an effect opposite to anxiolytic.
Does the term kush in the name indicate kinship with other kush strains?
No. In this listing, the name with this component is shared by ten cultivars, and half of them do not have established parents at all. A common word in the name is not evidence of kinship in either direction.
Is Blood Orange Kush consistently available in pharmacies?
There is no such guarantee with one supplier. A break in supplies or a change in wholesale orders can remove the strain from the shelf for many weeks, and the current state is summarized by the list of currently available strains.
Hemp flower is a pharmaceutical raw material dispensed exclusively by prescription in the Rpw category. The above text is for informational purposes only, does not replace medical consultation, and is not an encouragement to use. The material was prepared by the editorial team of ubucha.pl.
